AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab (December 27, 2002). doi:10.1152/ajpendo.00308.2002
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
284/4/E695    most recent
00308.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gustavson, S. M.
Right arrow Articles by Cherrington, A. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gustavson, S. M.
Right arrow Articles by Cherrington, A. D.
Submitted on July 11, 2002
Accepted on December 19, 2002

Interaction of Glucagon and Epinephrine in the Control of Hepatic Glucose Production in the Conscious Dog

Stephanie M. Gustavson1*, Chang An Chu1, Makoto Nishizawa1, Ben Farmer1, Doss Neal2, Ying Yang2, E. Patrick Donahue2, Paul Flakoll2, and Alan D. Cherrington3

1 Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN, USA
2 Diabetes Research and Training Center, Vanderbilt University, Nashville, TN, USA
3 Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN, USA; Diabetes Research and Training Center, Vanderbilt University, Nashville, TN, USA

* To whom correspondence should be addressed. E-mail: stephanie.m.gustavson{at}vanderbilt.edu.

Epinephrine increases net hepatic glucose output (NHGO) mainly via increased gluconeogenesis, while glucagon increases NHGO mainly via increased glycogenolysis. The aim of the present study was to determine how the two hormones interact in controlling glucose production. In 18-h fasted conscious dogs a pancreatic clamp initially fixed insulin and glucagon at basal levels, following which one of four protocols was instituted. In G+E glucagon (1.5 ng/kg/min; portally) and epinephrine (50 ng/kg/min; peripherally) were increased, in G glucagon was increased alone, in E epinephrine was increased alone, and in C neither were increased. In G, E, and C, glucose was infused to match the hyperglycemia seen in G+E (~250 mg/dl). The areas under the curve for the increase in NHGO, after subtracting the change in C, were as follows: G=661±185, E=424±158, G+E=1178±57 mg/kg. Therefore, the overall effects of the two hormones on NHGO were additive. Additionally, glucagon exerted its full glycogenolytic effect while epinephrine exerted its full gluconeogenic effect, such that both processes increased significantly during concurrent hormone administration.




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. M. Breckenridge, B. Raju, A. M. Arbelaez, B. W. Patterson, B. A. Cooperberg, and P. E. Cryer
Basal insulin, glucagon, and growth hormone replacement
Am J Physiol Endocrinol Metab, November 1, 2007; 293(5): E1303 - E1310.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. Everett-Grueter, D. S. Edgerton, E. P. Donahue, S. Vaughan, C. A. Chu, D. K. Sindelar, and A. D. Cherrington
The effect of an acute elevation of NEFA concentrations on glucagon-stimulated hepatic glucose output
Am J Physiol Endocrinol Metab, September 1, 2006; 291(3): E449 - E459.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. C. Moore, C. A. DiCostanzo, D. Dardevet, M. Lautz, B. Farmer, and A. D. Cherrington
Interaction of a selective serotonin reuptake inhibitor with insulin in the control of hepatic glucose uptake in conscious dogs
Am J Physiol Endocrinol Metab, March 1, 2005; 288(3): E556 - E563.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. A. Guy, D. Sandoval, M. A. Richardson, D. Tate, P. J. Flakoll, and S. N. Davis
Differing physiological effects of epinephrine in type 1 diabetes and nondiabetic humans
Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E178 - E186.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. C. Connolly, L. N. Aglione, M. S. Smith, D. B. Lacy, and M. C. Moore
Pregnancy impairs the counterregulatory response to insulin-induced hypoglycemia in the dog
Am J Physiol Endocrinol Metab, September 1, 2004; 287(3): E480 - E488.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
L. A. Hornbuckle, C. A. Everett, C. C. Martin, S. S. Gustavson, C. A. Svitek, J. K. Oeser, D. W. Neal, A. D. Cherrington, and R. M. O'Brien
Selective stimulation of G-6-Pase catalytic subunit but not G-6-P transporter gene expression by glucagon in vivo and cAMP in situ
Am J Physiol Endocrinol Metab, May 1, 2004; 286(5): E795 - E808.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. M. Gustavson, C. A. Chu, M. Nishizawa, B. Farmer, D. Neal, Y. Yang, S. Vaughan, E. P. Donahue, P. Flakoll, and A. D. Cherrington
Glucagon's actions are modified by the combination of epinephrine and gluconeogenic precursor infusion
Am J Physiol Endocrinol Metab, September 1, 2003; 285(3): E534 - E544.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2002 by the American Physiological Society.